---
document_datetime: 2023-09-21 21:15:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/skytrofa-previously-lonapegsomatropin-ascendis-pharma-epar-all-authorised-presentations_en.pdf
document_name: skytrofa-previously-lonapegsomatropin-ascendis-pharma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.4098021
conversion_datetime: 2025-12-21 19:48:47.734813
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EMA Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/21/1607/001   | Skytrofa   | 3 mg    | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 3 mg; solvent: 0.279 ml; (11 mg/ml)    | 4 cartridges + 6 needles   |
|--------------------|------------|---------|-------------------------------------------------|--------------------|----------------------------------|------------------------------------------------|----------------------------|
| EU/1/21/1607/002   | Skytrofa   | 3.6 mg  | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 3.6 mg; solvent: 0.329 ml; (11 mg/ml)  | 4 cartridges + 6 needles   |
| EU/1/21/1607/003   | Skytrofa   | 4.3 mg  | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 4.3 mg; solvent: 0.388 ml; (11 mg/ml)  | 4 cartridges + 6 needles   |
| EU/1/21/1607/004   | Skytrofa   | 5.2 mg  | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 5.2 mg; solvent: 0.464 ml; (11 mg/ml)  | 4 cartridges + 6 needles   |
| EU/1/21/1607/005   | Skytrofa   | 6.3 mg  | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 6.3 mg; solvent: 0.285 ml; (22 mg/ml)  | 4 cartridges + 6 needles   |
| EU/1/21/1607/006   | Skytrofa   | 7.6 mg  | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 7.6 mg; solvent: 0.338 ml; (22 mg/ml)  | 4 cartridges + 6 needles   |
| EU/1/21/1607/007   | Skytrofa   | 9.1 mg  | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 9.1 mg; solvent: 0.400 ml; (22 mg/ml)  | 4 cartridges + 6 needles   |
| EU/1/21/1607/008   | Skytrofa   | 11 mg   | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 11 mg; solvent: 0.479 ml; (22 mg/ml)   | 4 cartridges + 6 needles   |
| EU/1/21/1607/009   | Skytrofa   | 13.3 mg | Powder and solvent for solution for injection   | Subcutaneous use   | Dual-chamber cartridge (glass)   | Powder: 13.3 mg; solvent: 0.574 ml; (22 mg/ml) | 4 cartridges + 6 needles   |